BioGenetics CO.,LTD. (KOSDAQ:A044480) announced a private placement of series 3 bearer-of-money guarantor private equity convertible bonds for gross proceeds of KRW 20,000,000,000 on November 6, 2019. The transaction will involve participation from Widwin Investment Co., Ltd., SJ Equity, Avitridge Trading Co., Ltd. and LC Bio Consortium for KRW 5,000,000,000 each. The bonds will mature on November 27, 2022 and have a yield to maturity and coupon rate of 5%. The bonds will be fully convertible into 2,642,007 common shares of the company, representing 20.42% stake in the company at a conversion price of KRW 7,570 per share from November 27, 2020 to November 26, 2022. The transaction is expected to close by November 27, 2019. The transaction has been approved by the board of directors of the company.